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Background: Heavy metal exposure may contribute to inflammation in the lungs via increased 
oxidative stress, resulting in tissue destruction and obstructive lung function (OLF). In this study, 
we evaluated the relationship between lead and cadmium levels in blood, and lung function in 
the Korean population.
Methods: Pooled cross-sectional data from 5,972 subjects who participated in the Korean 
National Health and Nutrition Examination Survey 2008–2012 were used for this study. OLF 
was defined as forced expiratory volume in 1 second/forced vital capacity (FEV
1
/FVC) ,0.7. 
Graphite-furnace atomic absorption spectrometry was used to measure levels of lead and 
cadmium in blood.
Results: Adjusted means for age, sex, body mass index, and smoking status in blood lead and 
cadmium levels were increased with age and were higher in men and current smokers. The 
FEV
1
/FVC ratio was lower in the highest quartile group of lead (78.4% vs 79.0%; P=0.025) 
and cadmium (78.3% vs 79.2%; P,0.001) concentrations, compared with those in the low-
est quartile groups. Multiple linear regression demonstrated an inverse relationship between 
the FEV
1
/FVC ratio and concentrations of lead (estimated -0.002; P=0.007) and cadmium 
(estimated -0.005; P=0.001). Of the 5,972 subjects, 674 (11.3%) were classified into the OLF 
group. Among current smokers, the risk of OLF was higher in subjects in the highest quartile 
group of cadmium concentration than in those in the lowest quartile group (odds ratio 1.94; 
95% confidence interval 1.06–3.57).
Conclusion: We demonstrated a significant association between the FEV
1
/FVC ratio and blood 
concentrations of lead and cadmium in the Korean population. The risk for OLF was elevated 
with increasing concentrations of cadmium among current smokers.
Keywords: lead, cadmium, pulmonary function, obstructive lung disease
Introduction
COPD is an important cause of morbidity and mortality worldwide. Although the 
most critical risk factor for development of COPD is cigarette smoking, 20%–30% 
of COPD patients have never smoked.1–3 Occupational exposures and air pollution 
have been associated with development and progression of COPD.4,5 Inhalation of 
airborne pollutants, including oxidant gases such as ozone, nitrogen dioxide, or par-
ticulate air pollution, may lead to activation of pulmonary inflammatory processes 
and lung damage.6
Heavy metal exposure may also contribute to increased oxidative stress, disruption 
of barrier mechanisms, and impaired DNA repair, resulting in inflammation and tissue 
destruction in the lungs, manifesting clinically as obstructive lung disease.6 Only a few 
observational studies have demonstrated the association between pulmonary disease 
Correspondence: Ji Ye Jung
Division of Pulmonology, Department 
of Internal Medicine, Institute of Chest 
Disease, severance hospital, Yonsei 
University College of Medicine, 50-1 
Yonsei-ro, seodaemun-gu, seoul 120-752, 
republic of Korea
Tel +82 10 3141 2576
Fax +82 2 393 6884
email stopyes@yuhs.ac 
Journal name: International Journal of COPD
Article Designation: Original Research
Year: 2015
Volume: 10
Running head verso: Leem et al
Running head recto: Heavy metals and lung function
DOI: http://dx.doi.org/10.2147/COPD.S86182
International Journal of COPD 2015:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1560
leem et al
and heavy metal exposure (including lead and cadmium).7–9 
Recently, a study of a large sample of the US population 
found a significant relationship between obstructive lung dis-
ease and concentrations of cadmium and lead in the blood.10 
It also demonstrated a dose-dependent inverse association 
between forced expiratory volume in 1 second (FEV
1
) % 
predicted and serum heavy lead and cadmium levels.10
Lead and cadmium can enter the body through the vari-
ous routes of ingestion, inhalation, and skin absorption.8,9,11,12 
In previous studies of the Korean population, the systemic 
effects of lead and cadmium on renal function and diabetes 
were reported.13,14 Lead and cadmium levels in the blood were 
associated with reduced epidermal growth factor receptor, 
but were not associated with prevalence of diabetes in the 
general Korean population. However, their effect on the lung 
has not been evaluated in the Korean population.
The aim of this study was to assess the association 
between lead and cadmium concentrations in the blood and 
lung function in a large representative sample of the Korean 
population.
Methods
study populations
This cross-sectional study analyzed pooled data during 
2 years (2008–2009) of the Korean National Health and Nutri-
tion Examination Surveys (KNHANES) IV (2007–2009) 
and the 3 years of KNHANES V (2010–2012). KNHANES 
is an ongoing cross-sectional survey of the civilian, non-
institutionalized Korean population.15 The methodology of 
the survey has been described previously.3 A multistage, 
stratified, probability sampling method was used, and house-
holds for sampling units were selected based on age, sex, 
and geographical area.
Participants were informed that their household had 
been randomly selected to participate in this survey per-
formed by the Korean Centers for Disease Control and 
Prevention. They were given the right to refuse, and all 
participants signed an informed consent form. The survey 
comprised a health interview survey, a nutrition survey, 
and a health examination survey. Data were collected by 
household interviews and by direct standardized physi-
cal examinations and fasting blood sampling conducted 
in mobile health examination centers. Spirometry was 
performed by specially trained technicians, using the 
same type of dry rolling seal spirometer (model 2130, 
Sensormedics Corporation, Torba Linda, CA, USA) for 
all subjects. The electronically generated spirometric 
data were transferred via the Internet to the review center. 
Two trained nurses reviewed the test results and provided 
quality control feedback to the technicians. Among 44,433 
subjects whom participated in the survey between 2008 and 
2012, we identified 5,972 subjects aged $20 years who 
completed spirometry according to the American Thoracic 
Society guidelines and whose lead and cadmium levels in 
the blood were measured.16 The Korean Centers for Disease 
Control and Prevention obtained written and informed 
consent from all participants, and the institutional review 
board at Severance Hospital approved the study protocol 
(4-2013-0803).
Definitions
Cigarette smoking status was categorized according to ques-
tionnaire items, including “Have you smoked at least 100 
cigarettes in your entire life?” and “Are you currently smok-
ing?”. Current smokers were defined by self-reported active 
smoking. All self-reported non-active smokers were classi-
fied as former smokers (smoked at least 100 cigarettes in their 
entire life) or never smokers (smoked less than 100 cigarettes 
in their entire life) based on survey question responses. Ever 
smokers included current and former smokers. Obstructive 
lung function (OLF) was defined as pre-bronchodilator FEV
1
/
forced vital capacity (FVC) ,0.7.17
Measurement of lead and cadmium in 
whole blood
Blood samples were collected in fasting state during the 
surveys with prior agreement. Graphite-furnace atomic 
absorption spectrometry with Zeeman background correction 
(Analyst 600; Perkin Elmer, Finland) was used to measure 
lead and cadmium in blood. All blood metal analyses were 
performed at the Neodin Medical Institute, a laboratory certi-
fied by the Korean Ministry of Health and Welfare.
Classification of subjects
Subjects were categorized into quartiles for each heavy 
metal as the 25th percentile (group 1), the 50th percentile 
(group 2), the 75th percentile (group 3), and the 100th per-
centile (group 4).
statistical analysis
Categorical variables were analyzed using chi-square tests 
and continuous variables were analyzed using a t-test between 
non-OLF and OLF groups. The blood levels of lead and 
cadmium were log-transformed because the distribution of 
lead and cadmium levels was likely skewed in the rightward 
direction. Analysis of covariance was used to estimate the 
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adjusted means of continuous variables (ie, blood lead and 
cadmium levels, FEV
1
, FVC, and FEV
1
/FVC ratio), with 
independent variables (ie, age, sex, body mass index [BMI], 
and smoking status). To compare the adjusted means for 
blood lead and cadmium levels, adjusted factors include 
age, sex, BMI, and smoking status. To compare the adjusted 
means of the FEV
1
, FVC, and FEV
1
/FVC ratio, blood lead 
and cadmium levels were also considered respectively. Mul-
tivariate linear regression adjusted for age, sex, BMI, and 
smoking status was performed to evaluate the effect of blood 
lead and cadmium levels on lung function. The prevalence of 
OLF was calculated in the quartile groups using multivariate 
logistic regression with adjustment for age, sex, and BMI. 
The statistical analysis was performed using SAS Enterprise 
Guide version 5.1.
Results
Adjusted means in blood lead and 
cadmium levels by age, sex, BMI, and 
smoking status
Table 1 displays the adjusted mean blood lead and cadmium 
concentrations for the main covariates, including age, 
sex, BMI, and smoking. The blood lead level increased 
with age until 60 years, was higher in men than in women 
(2.92 μg/dL vs 2.33 μg/dL; P,0.001), and was higher 
in current smokers than in former or never smokers 
(2.93 μg/dL vs 2.66 μg/dL and 2.49 μg/dL; P,0.001). 
The blood cadmium level increased with age until 60 
years, was higher in women than in men (0.96 μg/dL vs 
1.56 μg/dL; P,0.001), and was higher in current smokers 
than in former or never smokers (1.68 μg/dL vs 1.17 μg/
dL and 1.09 μg/dL; P,0.001).
lung function corresponding to blood 
lead and cadmium levels adjusted by age, 
sex, BMI, and smoking
Table 2 demonstrates the mean for FEV
1
, FVC, and FEV
1
/
FVC ratio by quartile of blood lead and cadmium levels after 
adjusting for age, sex, BMI, and smoking status. The means 
for FEV
1
, FVC, and FEV
1
/FVC ratio according to stratifica-
tion of age, sex, BMI, and smoking status are presented in 
Tables S1 and S2. FEV
1
 and FVC was lowest in the low-
est quartile (group 1) of lead concentration (#1.85 μg/L) 
compared with the other three quartile groups, and the 
Table 1 Mean and mean difference in blood lead and cadmium concentrations for the main covariates, including age, sex, BMI, and 
smoking status
Variable n Blood lead level P-value Blood cadmium level P-value
Mean (SE) Mean difference (SE) Mean (SE) Mean difference (SE)
age, years**
#41 1,400 2.28 (0.03) ref 0.93 (0.02) ref
42–50 1,447 2.54 (0.03) 0.25 (0.05) ,0.001 1.27 (0.02) 0.34 (0.02) ,0.001
51–59 1,552 2.86 (0.03) 0.57 (0.04) ,0.001 1.40 (0.02) 0.47 (0.02) ,0.001
$60 1,516 2.81 (0.03) 0.53 (0.05) ,0.001 1.39 (0.02) 0.46 (0.02) ,0.001
P-value for Wald F statistic ,0.001 ,0.001
sex
Male 3,018 2.92 (0.03) ref 0.96 (0.01) ref
Female 2,897 2.33 (0.03) -0.59 (0.04) ,0.001 1.56 (0.01) 0.60 (0.02) ,0.001
P-value for Wald F statistic ,0.001 ,0.001
BMI, kg/m2**
#22.06 1,487 2.66 (0.03) ref 1.23 (0.02) 0.01 (0.02)
22.07–24.02 1,481 2.60 (0.03) -0.06 (0.04) 0.180 1.24 (0.02) 0.01 (0.02) 0.678
24.03–26.05 1,475 2.63 (0.03) -0.03 (0.04) 0.443 1.27 (0.02) 0.04 (0.02) 0.055
$26.06 1,480 2.64 (0.03) -0.02 (0.04) 0.654 1.26 (0.02) 0.03 (0.02) 0.182
P-value for Wald F statistic 0.592 0.209
smoking
Current 1,438 2.93 (0.04) ref 1.68 (0.02) ref
Former 1,225 2.66 (0.04) -0.27 (0.05) ,0.001 1.17 (0.02) -0.51 (0.03) ,0.001
never 3,252 2.49 (0.03) -0.44 (0.05) ,0.001 1.09 (0.01) -0.58 (0.03) ,0.001
P-value for Wald F statistic ,0.001 ,0.001
Notes: Data were adjusted for all variables other than the main covariates, and are presented as the adjusted mean (SE) and mean difference (SE) unless otherwise indicated; 
**subjects were categorized into four groups for age and BMI as the 25th percentile, the 50th percentile, the 75th percentile, and the 100th percentile. 
Abbreviations: BMI, body mass index; SE, standard error; Ref, reference.
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dose–response relationship was not significant. However, 
the FEV
1
/FVC ratio was lower in the highest quartile of lead 
concentration than in the lowest quartile (78.4% vs 79.0%; 
P=0.025).
There was no difference in FEV
1
 between the lowest 
quartile (#0.77 μg/L) and highest quartile ($1.57 μg/L) of 
cadmium concentration. FVC was higher in subjects in the 
highest quartile than in those in the lowest quartile, but the 
dose–response relationship was not significant. The FEV
1
/
FVC ratio was lower in the highest quartile than in the lowest 
quartile (78.3% vs 79.2%; P,0.001).
Adjusted estimates of lead and cadmium 
levels associated with lung function
Table 3 shows the adjusted estimates of lead and cadmium 
levels associated with lung function according to multiple 
linear regression after log-transformation. On adjustment for 
age, sex, and smoking status, the FEV
1
/FVC ratio decreased 
with increasing concentrations of lead (estimated -0.002; 
P=0.007) and cadmium (estimated -0.005; P=0.001). 
However, blood levels of lead and cadmium were not 
significantly related to FEV
1
 or FVC. On stratification 
for smoking status (never, former, and current), the blood 
lead level was associated with FEV
1
/FVC only in never 
smokers (estimated= -0.003, P=0.007) while the blood 
cadmium level was associated with FEV
1
/FVC in both for-
mer and current smokers (estimated= -0.011, P=0.016 and 
estimated= -0.008, P=0.002, respectively).
Baseline characteristics and blood lead 
and cadmium levels between non-OlF 
and OlF groups
Among the 5,972 subjects, 5,298 (88.7%) was classified 
as the non-OLF group and 674 (11.3%) as the OLF group. 
The demographic and clinical characteristics of the study 
population are shown in Table 4. The OLF group was 
older than the non-OLF group (59.7 years vs 49.3 years; 
P,0.001) and contained a higher percentage of males 
(75.6% vs 48.0%; P,0.001) than the non-OLF group. 
Moreover, the OLF group contained a higher proportion of 
ever smokers (70.4% vs 41.8%; P,0.001). The mean levels 
of lead (2.77 μg/dL vs 2.36 μg/dL; P,0.001) and cadmium 
(1.18 μg/dL vs 1.06 μg/dL; P,0.001) in the OLF group were 
higher than in the non-OLF group. Regardless of smoking 
status, lead levels in the blood were all higher in the OLF 
group than in the non-OLF group. However, cadmium levels 
were higher in the OLF group than in the non-OLF group 
among ever smokers.T
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Table 3 Adjusted estimates of blood lead and cadmium levels for lung function according to multiple linear regression
Dependent  
parameters
Estimated SE P-value Estimated SE P-value
Lead Cadmium
all*
FeV1, l -0.000006 0.059 0.999 0.003 0.009 0.761
FVC, l 0.009 0.006 0.147 0.029 0.002 0.336
FeV1/FVC, % -0.002 0.001 0.007 -0.005 0.001 0.001
never smoker**
FeV1, l 0.0006 0.007 0.930 0.006 0.011 0.602
FVC, l 0.012 0.009 0.164 0.017 0.013 0.197
FeV1/FVC, % -0.003 0.001 0.007 -0.002 0.002 0.299
Former smoker**
FeV1, l -0.0002 0.011 0.987 0.045 0.03 0.142
FVC, l 0.0047 0.013 0.707 0.115 0.036 0.001
FeV1/FVC, % -0.00078 0.002 0.623 -0.011 0.005 0.016
Current smoker**
FeV1, l 0.002 0.009 0.807 -0.022 0.019 0.272
FVC, l 0.008 0.011 0.489 0.019 0.023 0.406
FeV1/FVC, % -0.001 0.001 0.281 -0.008 0.003 0.002
Notes: *Adjusted for age, sex, smoking status (never, former, and current smoker), and body mass index; **adjusted for age, sex, and body mass index.
Abbreviations: FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; SE, standard error.
Table 4 Baseline characteristics between non-OlF and OlF 
groups*
Baseline  
characteristics
Non-OLF OLF P-value
(n=5,298) (n=674)
age, years 49.3±12.4 59.7±11.8 ,0.001
Male 2,545 (48.0) 510 (75.6) ,0.001
BMI, kg/m2 24.2±3.0 23.6±2.9 ,0.001
Smoking status**
never smoker 3,057 (58.1) 197 (29.5) ,0.001
ever smoker 2,199 (41.8) 470 (70.4)
Former smoker 990 (45.0) 238 (50.6) 0.027
Current smoker 1,209 (54.9) 232 (49.3)
Lead
Total, μg/dl 2.36 (2.33, 2.38) 2.77 (2.68, 2.86) ,0.001
smoking status
never, μg/dl 2.10 (2.07, 2.13) 2.27 (2.13, 2.42) 0.014
Former, μg/dl 2.72 (2.65, 2.78) 2.88 (2.74, 3.04) 0.033
Current, μg/dl 2.81 (2.75, 2.88) 3.13 (2.98, 3.28) ,0.001
Cadmium
Total, μg/dl 1.06 (1.04, 10.8) 1.18 (1.14, 1.23) ,0.001
smoking status
never, μg/dl 1.08 (1.06, 1.10) 1.09 (1.01, 1.18) 0.781
Former, μg/dl 0.86 (0.83, 0.89) 1.00 (0.94, 1.06) ,0.001
Current, μg/dl 1.21 (1.17, 1.24) 1.50 (1.42, 1.59) ,0.001
Notes: *Data are presented as numbers (percentages), and plus–minus values are 
the mean ± standard deviation unless otherwise indicated; **data of smoking status 
were not available in 18 subjects in the non-OLF group and in two subjects in the 
OlF group. 
Abbreviations: OLF, obstructive lung function; BMI, body mass index.
Prevalence and adjusted odds ratio for 
OlF according to heavy metal category
Figure 1 demonstrates the prevalence of OLF in the quartile 
groups according to lead and cadmium levels. We observed 
that the prevalence of OLF increased among current smokers 
when lead levels increased (P=0.004), but there was no 
significant dose–response relationship in former and never 
smokers. The prevalence of OLF increased among former and 
current smokers when cadmium levels increased (P,0.004), 
but there was no significant dose–response relationship in 
never smokers.
Figure 2 demonstrates the odds ratios and 95% confi-
dence intervals for the prevalence of OLF in the quartile 
groups compared to the reference group of the lowest 
quartile according to lead and cadmium levels. The odds 
ratio was evaluated after adjustment for age, sex, and 
BMI. There was no significant association between the 
prevalence of OLF and lead concentrations in never, for-
mer, or current smokers. However, the risk for OLF was 
significantly higher for subjects in the highest quartile of 
cadmium concentration (odds ratio 1.94; 95% confidence 
interval 1.06–3.57) than for those in the lowest quartile 
among current smokers.
Discussion
In this study, we demonstrated a significant association 
between the FEV
1
/FVC ratio and lead and cadmium levels 
in the blood in a large nationally representative sample of 
the Korean population. Upon adjusted analysis, the FEV
1
/
FVC ratio decreased as the blood concentrations of lead 
and cadmium increased. We also evaluated the relationship 
of OLF with lead and cadmium levels. The OLF group had 
higher levels of lead and cadmium than the non-OLF group 
and the prevalence of OLF increased as the level of lead 
and cadmium increased, especially among current smokers. 
According to adjusted analysis, the risk of OLF was higher in 
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subjects with cadmium concentrations in the highest quartile 
when compared with those with the lowest quartile among 
current smokers.
Although the levels of lead and cadmium were associated 
with the FEV
1
/FVC ratio and prevalence of OLF, overall lev-
els of heavy metals in the blood were lower than those stated 
by current safety standards.18 For both lead and cadmium, 
blood levels of 5 μg/dL or higher are considered to increase 
the risk of adverse systemic health effects.19,20
Recently, Rokadia and Agarwal reported a significant 
relationship between heavy metal exposure based on blood 
levels of lead and cadmium and obstructive lung disease in a 
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large representative sample in the USA.10 The risk of obstruc-
tive lung disease was elevated with increased concentrations 
of lead and cadmium. A dose–response effect between 
increasing cadmium concentration and progressively wors-
ening lung function (FEV
1
 %predicted) was observed only 
in smokers. However, a dose-dependent inverse association 
between increasing lead concentration and worsening lung 
function (FEV
1
 %predicted) was observed in both smok-
ers and never smokers. They suggested that cadmium may 
mediate the association between smoking and obstructive 
lung disease.10
Our study also analyzed the relationship of blood lead and 
cadmium levels with lung function and prevalence of OLF. 
Compared with the study of Rokadia and Agarwal our study 
showed a higher level of lead and a lower level of cadmium 
in blood. A higher proportion of subjects in their study were 
current smokers, which could be one of the reasons for the 
higher blood level of cadmium. Moreover, as the food chain 
is a major route of lead exposure, a higher level of cadmium 
may be related to boiled rice, which is a staple food in Korea.21 
Particulate matter (PM)
10
 is one of the sources of heavy metals. 
Over 53% of PM
10
 in South Korea is estimated to be emitted 
from the vehicles with diesel engines.22 According to the study 
reported by Kim et al the average daily concentrations of PM
10
 
in the seven Korean cities were similar to that described in 
the World Health Organization Global Guidelines for ambi-
ent air quality.21
We included not only the FEV
1
, but also the FEV
1
/FVC 
ratio as indicators of airway obstruction. Although we failed 
to demonstrate a relationship between FEV
1
 and blood heavy 
metal levels, the FEV
1
/FVC ratio decreased with increasing 
concentrations of lead levels in never smokers and cadmium 
levels in ever smokers. A different distribution of blood 
lead and cadmium levels would contribute to the different 
relationship between blood heavy metal levels and lung func-
tion parameters when compared with Rokadia and Agarwal. 
Among ever smokers, the risk of OLF was elevated with 
increased concentrations of cadmium only. In the case of 
lead, the difference was not statistically significant between 
the different concentration quartiles regardless of smoking 
status. Therefore, this study also supports the previous report 
that cadmium may be associated with smoking-related risks 
of OLF.
Cadmium can enter humans via ingestion or inhalation. 
Ingestion is a major source of exposure in the general non-
smoking population, whereas inhalation exposure is primar-
ily seen in smokers.8,11 Cigarette smoking is a major source 
of cadmium exposure and increases the level of cadmium 
in the blood of smokers as much as four to five times that 
in non-smokers.24 Chronic exposure to cadmium leads to 
renal glomerular and tubular damage, disorders of calcium 
and bone metabolism, malignancy, and cardiovascular and 
respiratory disease.25 The mechanisms of the toxicity of heavy 
metals in the lung are still unclear. However, the induction 
of oxidative stress, disruption of barrier mechanisms and the 
extracellular matrix, and possible impaired DNA repair and 
apoptosis were considered to be related to the mechanism of 
cadmium toxicity in the lung according to the experimental 
models.23,26–29 Cadmium directly affects adherence junction 
proteins, resulting in barrier function disruption, disorga-
nizes the collagen cross-linking and elastin stabilizing the 
extracellular matrix, and accelerates collagen and elastin 
damage leading to emphysema.23,29 Cadmium also generates 
reactive oxygen species and induces impaired DNA repair 
and apoptosis.26,28,30–32
Among never smokers, occupational cadmium exposure 
has been considered a risk factor for the development of 
OLF.4 Increased urinary cadmium was associated with worse 
lung function and smoking-related emphysema.8,33 These 
negative effects are due to low excretion rate (a half-life 
as long as 15–20 years) of cadmium and its tendency for 
accumulation.34
Lead intake in humans occurs through ingestion, inha-
lation, and the skin. Airborne lead is deposited in soil and 
water. Thus, human exposure to lead occurs through the 
food chain and drinking water, which is the major exposure 
pathway for the general non-smoking adult population. 
Lead exposure through inhalation in the form of dust or 
vapor depends on several factors, such as occupation, 
tobacco use, and leisure activities.9,12 Cigarettes contain 
nearly 2.4 μg/g of lead, of which 5% is inhaled and the 
remainder is found in the ash and side stream smoke.12,35 
Although the respiratory system is one of the main routes 
of entry for lead, there are a limited number of studies 
regarding the effect of lead on the lungs, and most of these 
studies described the impact of lead on the hematopoietic, 
cardiovascular, reproductive, and nervous systems, as 
well as on renal disease.36,37 Lymphocyte and monocyte 
infiltration and collagen accumulation were evident in the 
interalveolar septa in the lung tissues of rats exposed to 
lead.38 Risk for lung cancer was reported among lead smelter 
workers in a lead cohort study.39 Pulmonary function was 
worse in battery and exhaust workers, who showed higher 
blood levels of lead than the controls.9 Likewise, we also 
found that the FEV
1
/FVC ratio was worse as the blood lead 
levels increased.
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This study has several limitations. First, it was a cross-
sectional observational study, so it is difficult to clarify 
the cause-and-effect relationship between cadmium and 
lead levels and lung function. Second, questions related to 
occupational exposure to lead or cadmium were not specifi-
cally asked, and data regarding dietary intake and amount of 
smoking were not considered in the analysis. However, the 
aim of this study was to investigate the relationship between 
heavy metal levels in the blood and lung function regardless 
of exposure and dietary intake. Subjects who are exposed to 
heavy metals through occupation, high dietary intake, and 
large amounts of smoking would likely show high levels 
of heavy metals in the blood. Lastly, the blood lead and 
cadmium levels were generally in the normal range because 
most participants in KNHANES are probably not exposed 
to an environment that is extremely contaminated with such 
chemicals. Therefore, there would be a limit to our ability to 
demonstrate a relationship between abnormally high blood 
levels of heavy metals and lung function.
Conclusion
In conclusion, we demonstrated a significant association 
between FEV
1
/FVC ratio and blood concentrations of lead 
and cadmium in the general Korean population. The OLF 
group had higher blood levels of lead and cadmium than 
the non-OLF group. The risk for OLF was elevated with 
increased concentrations of cadmium, especially among 
smokers. However, additional research with more etiologies 
is needed to elucidate the association between heavy metals 
and lung function.
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